PagrindinisAPNHY • OTCMKTS
add
Aspen Pharmacare Holdings ADR
Ankstesnė uždarymo kaina
9,42 $
Dienos intervalas
9,65 $ - 9,65 $
Metų intervalas
9,42 $ - 13,69 $
Bendroji vertė rinkoje
75,89 mlrd. ZAR
Vidutinė prekybos apimtis
174,00
Aktualios naujienos
Finansiniai rodikliai
Pajamų ataskaita
Pajamos
Grynosios pajamos
| (ZAR) | 2024-06info | Metinis pokytis |
|---|---|---|
Pajamos | 11,78 mlrd. | 9,30 % |
Veiklos sąnaudos | 2,36 mlrd. | −3,24 % |
Grynosios pajamos | 1,04 mlrd. | −18,17 % |
Grynojo pelno marža | 8,87 | −25,15 % |
Pelnas tenkantis vienai akcijai | — | — |
EBITDA | 2,93 mlrd. | 7,80 % |
Taikomas mokesčio tarifas | 25,52 % | — |
Balansas
Visas turtas
Visi įsipareigojimai
| (ZAR) | 2024-06info | Metinis pokytis |
|---|---|---|
Lėšos, trump. investicijos | 12,34 mlrd. | 13,06 % |
Visas turtas | 139,16 mlrd. | 3,63 % |
Visi įsipareigojimai | 54,29 mlrd. | 13,00 % |
Visos paprastosios akcijos | 84,86 mlrd. | — |
Išleistos akcijos | 444,21 mln. | — |
Kaina / apskaitinė vertė | 0,05 | — |
Turto grąža | 4,84 % | — |
Kapitalo grąža | 5,56 % | — |
Pinigų srautas
Grynasis pokytis (grynaisiais pinigais)
| (ZAR) | 2024-06info | Metinis pokytis |
|---|---|---|
Grynosios pajamos | 1,04 mlrd. | −18,17 % |
Pinigai iš operacijų | 1,88 mlrd. | −1,21 % |
Pinigai iš investicijų | −1,65 mlrd. | −79,92 % |
Pinigai iš finansavimo | −141,50 mln. | 52,91 % |
Grynasis pokytis (grynaisiais pinigais) | −200,00 mln. | −118,37 % |
Laisvas pinigų srautas | 525,31 mln. | −32,86 % |
Apie
Aspen Pharmacare Holdings Limited is a public multinational pharmaceutical company headquartered in uMhlanga, South Africa. Founded in 1997, it listed on the Johannesburg Stock Exchange in 1998, and purchased South African Druggists in 1999 before expanding into international markets. Currently the largest pharmaceutical company in Africa through aggressive mergers and expansion, with major manufacturing sites in locations such as Gqeberha in South Africa, Bad Oldesloe in Germany, Notre-Dame-de-Bondeville in France, and Oss, Netherlands, Aspen is known for manufacturing and distributing branded pharmaceuticals as well as generic HIV/AIDS antiretrovirals and cancer medications. Among other products, Aspen has also been involved in manufacturing the Janssen COVID-19 vaccine through "fill and finish", and has the rights to sell the product under its own brand name Aspenovax. The company's revenue in 2022 was R38.6 billion. In 2016 Aspen was fined for high prices on cancer drugs, and after an investigation Aspen committed to reduce prices for 5 years in the European Union. Wikipedia
Generalinis direktorius
Įkurta
1850
Pagrindinė būstinė
Svetainė
Darbuotojų skaičius
9 109
